New Radiologic Therapy is Available at Hackensack Meridian Mountainside Medical Center for Patients with Neuroendocrine Tumors
The New Jersey Department of Health licensed Hackensack Meridian Mountainside Medical Center to perform a radiation treatment called peptide receptor radionuclide therapy (PPRT) using the drug LUTATHERA® for adults with advanced, cancerous neuroendocrine tumors that develop in the gastrointestinal tract and pancreas. This drug is FDA-approved and has been used to treat patients since 2018.
Read More